FDA Label for Cisatracurium Besylate
View Indications, Usage & Precautions
Cisatracurium Besylate Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Package Label.Principal Display Panel
Container Label (20 mg/10 mL)
NDC 72758-0011-1
Cisatracurium Besylate Injection, USP
20 mg/10 mL*
(2 mg/mL)
WARNING: Paralyzing Agent
For Intravenous Injection
0.9% benzyl alcohol (added as a preservative)
10 mL Multiple-Dose Vial
Rx only
Carton Label (20 mg/10 mL)
NDC 72758-0011-1
Cisatracurium Besylate Injection, USP
20 mg/10 mL*
(2 mg/mL)
WARNING: Paralyzing Agent
For Intravenous Injection
0.9% benzyl alcohol (added as a preservative)
10 mL Multiple-Dose Vial
Rx only
Carton Label (20 mg/10 mL)
NDC 72758-0011-6
Cisatracurium Besylate Injection, USP
20 mg/10 mL*
(2 mg/mL)
WARNING: Paralyzing Agent
For Intravenous Injection
0.9% benzyl alcohol (added as a preservative)
10 x 10 mL Multiple-Dose Vial
Rx only
* Please review the disclaimer below.